Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
446. |
ECCT/25/07/02 | PROPS Trial Efficacy of probiotic supplementation in preterm and small for gestational age infants. A multi-centre, placebo-controlled, individually-randomised trial (Probiotics in preterm and small for gestational age infants, PROPS trial) |
Principal Investigator(s) 1. Meshack Liru Site(s) in Kenya 1. Homabay County Referral Hospital (Homa Bay county) 2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county) 3. Kisii Teaching and Referral Hospital (Kisii county) 4. Migori County Referral Hospital (Migori county) |
View |
447. |
ECCT/25/07/03 | PROPS Trial Efficacy of probiotic supplementation in preterm and small for gestational age infants. A multi-centre, placebo-controlled, individually-randomised trial |
Principal Investigator(s) 1. Joyce Akuka Site(s) in Kenya 1. Migori County Referral Hospital (Migori county) 2. Homabay County Referral Hospital (Homa Bay county) 3. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county) 4. Kisii Teaching and Referral Hospital (Kisii county) |
View |
448. |
ECCT/25/07/04 | PROPS Trial Efficacy of probiotic supplementation in preterm and small for gestational age infants. A multi-centre, placebo-controlled, individually-randomised trial (Probiotics in preterm and small for gestational age infants, PROPS trial) |
Principal Investigator(s) 1. Mourine Ikol Site(s) in Kenya 1. Kisii Teaching and Referral Hospital (Kisii county) 2. Homabay County Referral Hospital (Homa Bay county) 3. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county) 4. Migori County Referral Hospital (Migori county) |
View |
449. |
ECCT/14/11/01 | ZEBOV Trial A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the BPSC1001 (VSVΔG-ZEBOV) Ebola Virus Vaccine Candidate in Healthy Adult Volunteers in Kilifi, Kenya. |
Principal Investigator(s) 1. Philip Bejon 2. Patricia Njuguna Site(s) in Kenya KEMRI Wellcome Trust Research Programme |
View |
450. |
ECCT/21/02/01 | PTSD 102 TONIX A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants with PTSD Taken Daily at Bedtime (Protocol No. TNX-CY-P308). |
Principal Investigator(s) 1. Prof. Lukoye Atwoli Site(s) in Kenya 1. Moi Teaching and Referral Hospital/Moi University (Uasin Gishu county) 2. KEMRI Nairobi (Nairobi City county) 3. Aga Khan University Hospital (Nairobi City county) |
View |